IGC Pharma (IGC) Debt to Equity (2011 - 2026)
IGC Pharma (IGC) reported Debt to Equity of $0.04 for Q1 2026, up 68.24% year-over-year from $0.02 in Q1 2025, and down 46.16% quarter-over-quarter from $0.07 in Q4 2025.
IGC Pharma (IGC) Debt to Equity (2011 - 2026) Analysis & Trends
IGC Pharma (IGC) has 16 years of Debt to Equity data on file, last reported at $0.04 in Q1 2026.
- Debt to Equity for Q1 2026 came in at $0.04, up 68.24% year-over-year; the trailing twelve-month figure through Mar 2026 was $0.04 (up 68.24% YoY), and the FY2026 annual result was $0.04, up 68.24% from the prior year.
- Debt to Equity retreated to $0.04 in Q1 2026 per IGC's latest filing, from $0.07 in the prior quarter.
- Over five years, Debt to Equity peaked at $0.07 in Q4 2025 and troughed at $0.01 in Q1 2022.
- A 5-year average of $0.02 and a median of $0.02 in 2025 frame the typical range for Debt to Equity.
- The sharpest annual moves came in 2022 and 2025: Debt to Equity plunged 65.2% in 2022, then jumped 208.96% in 2025.
- A 5-year view of Debt to Equity shows it stood at $0.01 in 2022, then jumped by 98.03% to $0.02 in 2023, then soared by 40.45% to $0.02 in 2024, then jumped by 208.96% to $0.07 in 2025, then slumped by 46.16% to $0.04 in 2026.
- Business Quant data shows IGC's Debt to Equity at $0.04 in Q1 2026, $0.07 in Q4 2025, and $0.02 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 0.32 |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | - |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | IGC Pharma | 28.11 Mn | 27.85 Mn | - | 0.04 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.04 |
| Dec 31, 2025 | 0.07 |
| Sep 30, 2025 | 0.02 |
| Jun 30, 2025 | 0.02 |
| Mar 31, 2025 | 0.02 |
| Dec 31, 2024 | 0.02 |
| Sep 30, 2024 | 0.02 |
| Jun 30, 2024 | 0.02 |
| Mar 31, 2024 | 0.02 |
| Dec 31, 2023 | 0.02 |
| Sep 30, 2023 | 0.01 |
| Jun 30, 2023 | 0.01 |
| Mar 31, 2023 | 0.01 |
| Dec 31, 2022 | 0.01 |
| Sep 30, 2022 | 0.01 |
| Jun 30, 2022 | 0.01 |
| Mar 31, 2022 | 0.01 |
| Dec 31, 2021 | 0.01 |
| Sep 30, 2021 | 0.00 |
| Jun 30, 2021 | 0.00 |